PE27497A1 - Derivados de 1,5 benzodiazepina - Google Patents

Derivados de 1,5 benzodiazepina

Info

Publication number
PE27497A1
PE27497A1 PE1995266225A PE26622595A PE27497A1 PE 27497 A1 PE27497 A1 PE 27497A1 PE 1995266225 A PE1995266225 A PE 1995266225A PE 26622595 A PE26622595 A PE 26622595A PE 27497 A1 PE27497 A1 PE 27497A1
Authority
PE
Peru
Prior art keywords
react
compound
halogen
nhr6r7
alkylene
Prior art date
Application number
PE1995266225A
Other languages
English (en)
Inventor
Brad Richard Henke
Elizabeth Ellen Sugg
Cristopher Joseph Aquino
Milana Dezube
Timothy Mark Willson
Marcus Brackeen
Peter Walter Jeffs
Edward Martin Suh
Tanya Momtahen
Gavin Charles Hirst
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9407467A external-priority patent/GB9407467D0/en
Priority claimed from GB9420700A external-priority patent/GB9420700D0/en
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of PE27497A1 publication Critical patent/PE27497A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA GENERAL I, DONDE: R1 ES PREFERENTEMENTE ISOPROPILO; R2 ES PREFERENTEMENTE FENILO O 4-METOXIFENILO; p, q, r Y t son 0 o 1, SIEMPRE QUE SI r ES 0, ENTONCES t ES 0; R3, R5 Y R6 SON H O ALQUILO(C1-C6); R4 ES ALQUILENO(C1-C6) O ALQUENILENO(C2-C6); R7 ES FENILO OPCIONALMENTE SUSTITUIDO POR AMINO O HALOGENO, ENTRE OTROS O ES BICICLOHETEROARILO, ENTRE OTROS, Y SI n, p Y q SON 1 Y r ES 0, ENTONCES R7 NO ES INDOLILO; o NR6R7 FORMAN UN ANILLO DE 5, 6 o 7 MIEMBROS (DE 1, 2, 3 o 4 ATOMOS DE N, S, O: SIEMPRE QUE O o S NO ESTEN UNIDOS O ENTRELAZADOS ENTRE SI); R10 ES H O BENCILO, ENTRE OTROS; R11 ES H O CICLOALQUILO(C3-C6), ENTRE OTROS; R8 ES H, METILO O METOXI, ENTRE OTROS; m ES 0, 1, 2, 3 o 4; R9 ES FENILO O PIRIDILO, ENTRE OTROS; Y Y Z SON H, HALOGENO O SAL DE ADICION. TAMBIEN SE REFIERE A LOS PROCEDIMIENTOS DE PREPARACION, QUE COMPRENDEN: HACER REACCIONAR UN COMPUESTO II CON R7COOH, Y LO OBTENIDO HACERLO REACCIONAR CON NHR6R7; HACER REACCIONAR EL COMPUESTO II CON NHR6R7; HACER REACCIONAR UN COMPUESTO III CON R7(R4)pCH(R3)HALOGENO; HACER REACCIONAR UN COMPUESTO IV CON (CLCO)(CLOC)C(R8)(CH(R3)((R4)p(CO)rR7)). ESTOS COMPUESTOS ACTUAN COMO AGONISTAS DE LOS RECEPTORES CCK-A, QUE REGULA LA HORMONA GASTRINA Y COLECISTOCININA. SIENDO USADOS PARA SACIAR EL APETITO O EN EL TRATAMIENTO DE LA DIABETES, ENTRE OTROS
PE1995266225A 1994-04-15 1995-04-11 Derivados de 1,5 benzodiazepina PE27497A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407467A GB9407467D0 (en) 1994-04-15 1994-04-15 1,5 Benzodiazepine compounds
GB9420700A GB9420700D0 (en) 1994-10-14 1994-10-14 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
PE27497A1 true PE27497A1 (es) 1997-08-07

Family

ID=26304709

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995266225A PE27497A1 (es) 1994-04-15 1995-04-11 Derivados de 1,5 benzodiazepina

Country Status (12)

Country Link
US (1) US5859007A (es)
EP (1) EP0755384A1 (es)
JP (1) JPH09511999A (es)
AP (1) AP551A (es)
AU (1) AU2306295A (es)
CA (1) CA2186872A1 (es)
IL (1) IL113366A0 (es)
MA (1) MA23504A1 (es)
MX (1) MX9604770A (es)
PE (1) PE27497A1 (es)
TN (1) TNSN95039A1 (es)
WO (1) WO1995028391A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
US6768024B1 (en) 2000-08-04 2004-07-27 Lion Bioscience Ag Triamine derivative melanocortin receptor ligands and methods of using same
KR100840852B1 (ko) * 2004-05-25 2008-06-23 화이자 프로덕츠 인크. 테트라아자벤조[ｅ]아줄렌 유도체 및 이의 유사체
UA84208C2 (en) * 2004-05-25 2008-09-25 Пфайзер Продактс Инк. Tetraazabenzo(e)azulene derivatives and analogs thereof
US7442693B2 (en) 2004-05-28 2008-10-28 Smithkline Beecham Corporation Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
US7169773B2 (en) 2004-07-01 2007-01-30 Smithkline Beecham Corporation Compounds
EP2280008B1 (en) 2007-01-16 2013-05-29 Purdue Pharma L.P. Heterocyclic-substituted piperidines as orl-1 ligands
TW201322983A (zh) * 2007-08-31 2013-06-16 Purdue Pharma Lp 經取代之喹□啉型哌啶化合物及其用途
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
BR112012003871A2 (pt) 2009-08-21 2015-09-08 Otsuka Pharma Co Ltd processo para a produção de composto de benzo[b][1,4]diazepina-2,4-diona
DK2803662T3 (en) 2012-01-13 2017-05-01 Nippon Chemiphar Co P2X4 receptor antagonist
CN103880749B (zh) * 2014-02-26 2019-01-01 南通大学 一种3-甲基-5-吡唑甲酸甲酯的化学合成方法
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ，インク． Ｇｐｒ１１９アゴニスト
IL295825A (en) 2020-02-28 2022-10-01 Kallyope Inc gpr40 agonists
CN114716344B (zh) * 2022-04-02 2023-12-22 湖南科技大学 2-((2-乙酰氨基苯基)氨基)乙酰芳胺类化合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001408A (en) * 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
GB9308421D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9308431D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9315018D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
CZ286764B6 (en) * 1994-04-14 2000-06-14 Glaxo Wellcome Inc 5-Heterocyclo-1,5-benzodiazepine derivatives, process of their preparation and pharmaceutical preparation containing thereof

Also Published As

Publication number Publication date
AP551A (en) 1996-11-01
IL113366A0 (en) 1995-07-31
WO1995028391A1 (en) 1995-10-26
JPH09511999A (ja) 1997-12-02
AU2306295A (en) 1995-11-10
EP0755384A1 (en) 1997-01-29
AP9500731A0 (en) 1995-04-30
CA2186872A1 (en) 1995-10-26
US5859007A (en) 1999-01-12
MA23504A1 (fr) 1995-12-31
TNSN95039A1 (fr) 1996-02-06
MX9604770A (es) 1998-05-31

Similar Documents

Publication Publication Date Title
PE27497A1 (es) Derivados de 1,5 benzodiazepina
AR000039A2 (es) Compuestos de piridinosulfonamida sustituidos, composiciones herbicidas que los contienen, metodo para preparar estos compuestos y compuestosintermediarios.
ES2070175T3 (es) Derivados de acido 4-oxoquinolino-3-carboxilico, su preparacion y su uso.
SE7903392L (sv) Basiska respektive katjonaktiva sulfonsyragrupphaltiga monoazo- eller disazoforeningar
TW222636B (es)
FI940105A0 (fi) Menetelmä sertraliinivälituotteiden valmistamiseksi
AR004706A1 (es) Un compuesto derivado de benzoxazina y pirido-oxazina utiles como antimicrobianos, composicion farmaceutica que lo contienen, un metodo para preparar dichos compuestos e intermediarios utiles para dicho metodo.
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
LV10451A (lv) Benzociklohepteni benzoksepini un benzotiepini
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
GB9121456D0 (en) Triazole antifungal agents
PT1064281E (pt) Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
ZA896645B (en) Alpha a,alpha a-disubstituted n-cycloalkylalkylbenzylamines,process for their preparation,their use as a medicament and their synthesis intermediates
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
DK0594666T3 (da) Fremgangsmåde til fremstilling af sertralin
DK0711291T3 (da) N-(Piperidinyl-1-alkyl)-substituerede cyclohexancarboxylsyreamider som 5-HT1A-receptorantagonister
ES8702364A1 (es) Procedimiento para preparar nuevos derivados de benzazepinas.
SE8303913L (sv) Heterocykliska foreningar
PT96557A (pt) Processo para a preparacao de derivados de ergolina e de composicoes farmaceuticas que os contem
ES8401766A1 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
ES2038159T3 (es) Procedimiento para preparar derivados sustituidos de 2-aminoacetamida.
ES463570A1 (es) Un procedimiento para la preparacion de nuevos compuestos triciclicos biologicamente activos
ATE203533T1 (de) INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN
DE69414117D1 (de) 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten

Legal Events

Date Code Title Description
FX Voluntary withdrawal